When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADMA - ADMA Biologics: Under-The-Radar Biotech With Huge Potential Upside
ADMA Biologics Inc
ADMA Biologics (ADMA) has racked up two big FDA wins in the past couple months. In April, it received FDA approval for Asceniv, an intravenous immune globulin (“IVIG”) drug product for the treatment of Primary Humoral Immunodeficiency Disease (“PI”). In May, the FDA gave the nod to another of ADMA’s PI therapies, Bivigam.
Together, these approvals represent a major step forward for ADMA. The stock is up nearly 75% since the start of the year, but even that impressive run-up appears likely to be just the beginning of a much bigger upward run